She describes Recursion's work, and what the acquisition of Exscientia has brought to the company. Plus, how AI can not only help with drug design, but also safety and patient recruitment.
View all episodes
By BiotechTV
5
44 ratings
She describes Recursion's work, and what the acquisition of Exscientia has brought to the company. Plus, how AI can not only help with drug design, but also safety and patient recruitment.
30,635 Listeners
1,867 Listeners
1,087 Listeners
325 Listeners
6,083 Listeners
60 Listeners
9,844 Listeners
86 Listeners
34 Listeners
19 Listeners
260 Listeners
499 Listeners
0 Listeners
4 Listeners
2 Listeners
6 Listeners